India, Nov. 3 -- International Biotechnology Trust plc (IBT.L), an investment trust focused on the biotechnology sector, reported net income of £152.21 million for the financial year ended August 31, 2026, compared with a net loss of £1.17 million in the previous year.
Basic earnings per share from continuing operations rose to 474.87 pence from a loss of 3.29 pence per share.
The trust also reported a share price total return of 73.6% for the year, compared with a 52.3% return for the NASDAQ Biotechnology Index.
Its net asset value (NAV) total return was 64.7%, marking its fifth consecutive year of outperformance against the reference index.
FY 2026 Financial Performance:
Total revenue increased to £159.95 million from ...